Every story, newest first. Use Explore to filter by topic, disease area, technology, company, stage or format.
Companies + StocksBiotech companies tell two stories at once: one scientific, one financial. This educational guide, which is not investment advice, shows how to check primary sources like SEC EDGAR, ClinicalTrials.gov and FDA databases.
DeepTech + MedTechFrom over-the-counter glucose monitors to AI-enabled imaging software, medical devices are getting smaller, smarter and more autonomous. Here is what is authorized, what is still experimental, and what could slow things down.
DeepTech + MedTechNo bioprinted solid organ has been transplanted into a person, but bioprinting has produced striking lab and animal results. Here is what works today, what has reached early human testing, and what still stands in the way.
DeepTech + MedTechOrganoids and organ-on-a-chip systems let researchers test drugs on human tissue models before people. The early evidence is promising but specific, and the models still miss much of real human biology.
Companies + StocksMost medical products begin as university research, then pass through tech transfer offices, licences or spinouts, and the regulatory system. This guide maps each step and the reasons discoveries stall.
LongevitySome longevity metrics, like blood pressure, are backed by decades of evidence and clear actions. Others, like consumer biological-age tests, are promising research tools whose meaning for individuals is not yet settled.
AI + MedicinePersonalized computer models of the heart and in-silico trials are already used in research and regulation. Scaling them into a living digital twin for every patient raises hard questions of biology, validation and trust.
BreakthroughsHealth headlines often overstate early findings, sometimes before a journalist ever sees them. These seven questions help anyone judge a medical claim in about two minutes before sharing it.